Here is a summary of the clinical note with the essential information:

**Cancer Type:** Hepatocellular carcinoma (HCC)

**Morphology:** Not specified

**Cancer Stage:** Not specified

**Progression:** Recurrent HCC, with a new echogenic area in the medial aspect of the right lobe of the liver

**TNM Staging:** Not specified

**Prescribed Medications:**

* Clotrimazole 1 TROC PO 5X/DAY
* Vitamin D 50,000 UNIT PO 1X/WEEK
* Furosemide 40 mg PO DAILY
* Nadolol 20 mg PO DAILY
* Omeprazole 40 mg PO BID
* Spironolactone 150 mg PO DAILY
* Lactulose 30 mL PO QID
* Rifaximin 550 mg PO BID
* Simethicone 80 mg PO QID:PRN gas pain

**Diagnostic Tests:**

* Ultrasound (RUQ) showing a new echogenic area in the medial aspect of the right lobe of the liver
* MRI showing no changes concerning for HCC
* Blood tests (WBC, RBC, Hgb, Hct, MCV, MCH, MCHC, RDW, Plt, PTT, INR, Glucose, UreaN, Creat, Na, K, Cl, HCO3, AnGap, ALT, AST, AlkPhos, TotBili, Albumin)
* Urine test (Blood, Nitrite, Protein, Glucose, Ketone, Bilirubin, Urobilin, pH, Leuks)
* Cerebrospinal fluid (CSF) analysis (WBC, RBC, Polys, Glucose, TotProt)

**Surgical Interventions:** None

**Patient's Response to Treatment:** The patient remained afebrile and without signs of infection after stopping antibiotics. The patient was discharged with a plan for follow-up laboratory studies and an appointment with the primary care doctor.

Note: The patient has a history of HCC, HCV, EtOH cirrhosis, and has undergone TACE x2 and RFA. The patient is on the transplant list with a current MELD score of 9.